Vertex Pharmaceuticals (VRTX) EBT Margin (2009 - 2026)
Vertex Pharmaceuticals (VRTX) reported EBT Margin of 41.75% for Q2 2026, down 1.53 percentage points from 43.28% a year earlier and down 0.20 percentage points from the prior quarter.
Vertex Pharmaceuticals (VRTX) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vertex Pharmaceuticals' EBT Margin came in at 41.90%, up 3.60 percentage points year-over-year; for FY2025, it came in at 38.69%, up 36.43 percentage points from FY2024.
- EBT Margin has a five-year change of -11.54 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at 2.25% in FY2024 (-42.12 pp), 44.38% in FY2023 (-3.01 pp), 47.39% in FY2022 (+11.34 pp) and 36.05% in FY2021 (-14.18 pp).
- Five-year quarterly EBT Margin spans a low of -128.18% in Q2 2024 and a high of 54.57% in Q3 2021.
- Year over year, EBT Margin gained in three of the last eight quarters, with an average year-over-year change of +19.40 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2025 (a gain of 171.46 percentage points); the low point was Q2 2024 (a drop of 174.77 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 41.95% (Q1 2026), 41.72% (Q4 2025) and 42.22% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -4.34% |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 41.75% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.75% |
| Mar 31, 2026 | 41.95% |
| Dec 31, 2025 | 41.72% |
| Sep 30, 2025 | 42.22% |
| Jun 30, 2025 | 43.28% |
| Mar 31, 2025 | 26.37% |
| Dec 31, 2024 | 39.03% |
| Sep 30, 2024 | 44.16% |
| Jun 30, 2024 | -128.18% |
| Mar 31, 2024 | 47.54% |
| Dec 31, 2023 | 45.58% |
| Sep 30, 2023 | 47.48% |
| Jun 30, 2023 | 46.59% |
| Mar 31, 2023 | 37.54% |
| Dec 31, 2022 | 46.76% |
| Sep 30, 2022 | 50.40% |
| Jun 30, 2022 | 46.64% |
| Mar 31, 2022 | 45.52% |
| Dec 31, 2021 | 42.02% |
| Sep 30, 2021 | 54.57% |
Vertex Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();